Insights Into Cannabis and Cannabinoids: Chemical Properties, Legal Perspectives, and Therapeutic Applications.
This review covers cannabis cannabinoids therapeutic applications, highlighting chemical properties and legal perspectives. It synthesizes evidence from clinical trials and phytochemical studies. Understanding these applications aids clinicians in…
Cannabis Extracts Significantly Reduce Myofascial Pain | Trending – Labroots
Recent clinical evidence highlights cannabis extracts myofascial pain relief potential. These extracts show significant efficacy in reducing muscle tension and trigger points. This finding supports cautious consideration for patients with…
InMed Pharmaceuticals Focuses on Cannabinoid Therapeutic Development
InMed Pharmaceuticals' shift to cannabinoid therapeutic development marks a significant change in the industry. This move away from commodity cannabinoid production affects clinicians sourcing standardized cannabinoid products. The focus on cannabinoid…
TPS Cannabis News – StratCann Insights
TPS Cannabis News StratCann delivers the latest clinical updates on cannabis research and policy. This resource offers valuable insights for healthcare providers and patients. Stay informed with TPS Cannabis News StratCann for meaningful clinical…
Mom’s Homemade Medical Cannabis Recipe Now Sold at Georgia Dispensaries
A homemade cannabis oil formulation by a Georgia resident is now available in medical cannabis dispensaries. This transition raises critical questions about product standardization and regulatory oversight. Ensuring quality control in homemade cannabis…
In the Mix: 4 More Articles — March 17, 2026
This post reviews 4 cannabis articles clinical relevance as of March 17, 2026. The articles cover therapeutic evidence and policy developments relevant to clinicians. These insights help inform evidence-based cannabis medicine practice.
Study Reveals Limited Benefits of Medical Cannabis for Mental Health
This medical cannabis efficacy review reveals limited benefits for psychiatric conditions such as anxiety and depression. Clinicians should counsel patients carefully about cannabis use given the sparse robust evidence. The findings emphasize cautious…
Cannabinoids for Mental, Substance Use Disorders ‘Rarely Justified,’ Study Suggests
This article reviews cannabinoid clinical trials mental disorders evidence indicating limited efficacy for mental health and substance use disorders. The findings suggest cannabinoids offer minimal benefit for cannabis withdrawal and no advantage over…
Study Found CBD and CBG May Counter Fatty Liver Disease | Cannabis Sciences
Emerging research highlights hepatoprotective effects CBD CBG may provide in managing fatty liver disease. These cannabinoids show potential in reducing liver fat and improving function. Clinicians should consider this early evidence cautiously while…
‘No evidence’ cannabis works for most mental health disorders: Review – RACGP
This review highlights cannabis mental health conditions treatment lacks sufficient evidence for efficacy. Despite widespread use, most psychiatric disorders show no proven benefit. Clinicians must counsel patients on risks and evidence gaps.